A Phase 3 Study of 2 Dose Regimens of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin...... Grant uri icon

date/time interval

  • March 10, 2008 - March 24, 2011

total award amount

  • 161606.82

direct costs

  • 129285.46

sponsor award ID

  • VX07-950-108

local award ID

  • 00068352